Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas.
about
Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblastsCoamplification of human acetylcholinesterase and butyrylcholinesterase genes in blood cells: correlation with various leukemias and abnormal megakaryocytopoiesisNovel c-MYC target genes mediate differential effects on cell proliferation and migrationTelomerase: The Devil InsidePolyphenol Compound as a Transcription Factor InhibitorSGF29 and Sry pathway in hepatocarcinogenesisMYC activation is a hallmark of cancer initiation and maintenanceSuppression of Wnt signaling by the green tea compound (-)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells. Requirement of the transcriptional repressor HBP1Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosisThe c-Myc target gene Rcl (C6orf108) encodes a novel enzyme, deoxynucleoside 5'-monophosphate N-glycosidaseAutophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphomaDistal deletion of chromosome Ip in ductal carcinoma of the breast.Amplification of c-myc oncogene by chromogenic and fluorescence in situ hybridization in archival breast cancer tissue array samples.A core MYC gene expression signature is prominent in basal-like breast cancer but only partially overlaps the core serum responsec-Myc affects mRNA translation, cell proliferation and progenitor cell function in the mammary gland.Ligand activation of overexpressed epidermal growth factor receptors transforms NIH 3T3 mouse fibroblasts.MYC oncogenes and human neoplastic disease.Inactivation of MYC reverses tumorigenesis.Genomic alterations of primary tumor and blood in invasive ductal carcinoma of breastMYC Deregulation in Primary Human Cancers.Cellular oncogenes in neoplasiaCyclin D1 amplification and expression in human breast carcinoma: correlation with histological prognostic markers and oestrogen receptor expression.Evidence that the familial adenomatous polyposis gene is involved in a subset of colon cancers with a complementable defect in c-myc regulation.The int-2 gene product acts as an epithelial growth factor in transgenic micec-Myc target genes involved in cell growth, apoptosis, and metabolismDistinct cellular factors regulate the c-myb promoter through its E2F elementTransgenic mouse models of human breast cancer.Loss of heterozygosity on chromosome 1q in human breast cancer.MYC in breast tumor progressionRole of proto-oncogene activation in carcinogenesis.MYC and Breast Cancer.TGF-beta signaling engages an ATM-CHK2-p53-independent RAS-induced senescence and prevents malignant transformation in human mammary epithelial cells.Loss of amplified genes by poly(ADP-ribose) polymerase inhibitorsHuman breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells.Oncogenes and human breast cancer.Oncogenes and tumor suppressor genes: new biochemical tests.MYC gene amplification is often acquired in lethal distant breast cancer metastases of unamplified primary tumors.Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer.Cultured human atherosclerotic plaque smooth muscle cells retain transforming potential and display enhanced expression of the myc protooncogene.Targeted c-myc gene expression in mammary glands of transgenic mice induces mammary tumours with constitutive milk protein gene transcription
P2860
Q24292464-709EF10C-354C-4C9B-B5D6-255769B67E5DQ24610584-F00CC382-92E5-49EE-9501-8A46161E02EEQ24676528-9905874B-E0DC-4803-81B1-4A0CCF8F6C17Q26739948-C1761574-FA04-4DFA-8C46-71AA71511389Q26777064-8D963D95-595E-4AE5-A4CD-BEA448515FABQ26795760-122DFDE3-0244-41DF-897D-3632F9CECADFQ27026026-DD859C3E-2B99-444D-832E-712778E10B9EQ28298718-383C0F55-A9A1-443D-BD2B-E1C452A3AD2DQ28472991-473D4197-031B-462E-88E2-948D15C1441BQ28575753-14DB4B6B-74DD-462D-9B49-01F342B02C4EQ29622918-F1AA3709-7A1E-4301-9751-1F548AC4FE38Q30541684-13202F5C-8A05-4F5C-A858-649EAE67D42EQ31029884-8E899030-2B33-4585-84DB-3C1F352FCB47Q33494820-8A76164C-1936-421C-BE1F-260A2E84DE6FQ33507168-78269647-C481-42DC-9B32-5E8E26680322Q33556637-A327D536-CCE1-4BD5-9C38-42000723D69DQ33667340-A47E6096-264F-49E7-8A85-B6DE66FD75C3Q33784668-05F598B5-9D1E-4B84-82D1-9C6F7E5F4B49Q33833204-53216E7F-41EB-444B-951A-4D0160C88E78Q33836755-B5E56E5E-0947-4C27-93AC-1D3315B7E24BQ33838211-93F1F761-A65C-49C9-AD30-45AAF06DEA05Q33840107-30650B66-7A23-4A50-B682-799BC4E7BDACQ33867960-2E0CF134-269B-4AA3-9C4B-D5272F11682CQ33918611-AC1D8395-E31B-4DEA-B33C-A66E009AAC6DQ33956988-C19AA7B4-6600-45B9-9C00-2875BC4FBC50Q33960807-D79779E7-F9CC-498D-AFC8-C569FE1D6FABQ34130558-42066BF8-2966-4185-8D2F-F0D6459F5790Q34304686-25164B8E-C702-4613-813B-D051F0F31D59Q34524915-513117FE-4676-4DE9-A32F-23E2F1F90621Q34844276-6371CC27-E8CE-465D-95D6-0F47595BDE3DQ34972381-54970181-350A-47F1-81EC-A69455B80A05Q35008198-CCB53C21-92F7-499C-8614-05DB86912E7CQ35034213-7CD43F59-A93D-4805-995D-75E4550B0385Q35076272-007D6DD1-96F0-4672-8138-CFE56DEA801FQ35248134-CABF89AD-1AFD-4CAE-ADA6-37492FD28689Q35662775-010B78E3-B517-448B-812B-9C2F3746604AQ35748541-8B7BCD6C-2321-4419-8E6E-2150CB95E130Q35787051-ADF32DC4-7C9C-4C64-B1F9-91A5D10E1C9BQ35831005-B21F2258-1D18-45AA-9D21-66EFC69508DCQ35973719-7FE23536-E097-4131-B623-B67DAB453C1E
P2860
Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas.
@ast
Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas.
@en
type
label
Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas.
@ast
Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas.
@en
prefLabel
Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas.
@ast
Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas.
@en
P2093
P2860
P356
P1476
Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas.
@en
P2093
Callahan R
Champeme MH
Lidereau R
Spyratos F
Theillet C
P2860
P304
P356
10.1073/PNAS.83.13.4834
P407
P577
1986-07-01T00:00:00Z